Library of Congress subjects (96929)
R Medicine (9332)
RC Internal medicine (543)
RC0254 Neoplasms. Tumors. Oncology (including Cancer) (46)
Number of items at this level: 46.
Article
Affordability of cancer care in the United Kingdom: is it time to introduce user charges?
Aggarwal, Ajay; Sullivan, Richard
Challenges and opportunities for incentivising antibiotic research and development in Europe. (2023)
Anderson, Michael; Panteli, Dimitra; van Kessel, Robin; Ljungqvist, Gunnar; Colombo, Francesca; Mossialos, Elias
picture_as_pdf
Multiple criteria decision analysis for HTA across four EU member states:piloting the Advance Value Framework.
Angelis, Aris; Linch, Mark; Montibeller, Gilberto; Molina Lopez, Maria Teresa; Zawada, Anna; Orzel, Kinga; Arickx, Francis; Espin, Jaime; Kanavos, Panos
picture_as_pdf
Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage:an exploratory analysis of UKCTOCS.
Bedia, Jacob S.; Jacobs, Ian J.; Ryan, Andy; Gentry-Maharaj, Aleksandra; Burnell, Matthew; Singh, Naveena; Manchanda, Ranjit; Kalsi, Jatinderpal K.; Dawnay, Anne; Fallowfield, Lesley; McGuire, Alistair J.; Campbell, Stuart; Parmar, Mahesh K.B.; Menon, Usha; Skates, Steven J.
picture_as_pdf
Position paper by the UKCCCR Elderly Cancer Patients in Clinical Trials Working Group.
Blake, Peter; Evans, J. Grimley; Fallowfield, Lesley; Fentiman, Ian; Gosney, Margot; Grundy, Emily; Harper, Peter; Heath, Hazel; Heath, Iona; Khaw, Kay-Tee; Northover, John; Oliver, Gill; Speechley, Val; Twentyman, Peter; Whelan, Jane
A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer.
Brar, Savtaj S.; Seevaratnam, Rajini; Cardoso, Roberta; Law, Calvin; Helyer, Lucy; Coburn, Natalie G.
UKCTOCS update:applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis.
Burnell, Matthew; Gentry-Maharaj, Aleksandra; Skates, Steven J.; Ryan, Andy; Karpinskyj, Chloe; Kalsi, Jatinderpal; Apostolidou, Sophia; Singh, Naveena; Dawnay, Anne; Woolas, Robert; Fallowfield, Lesley; Campbell, Stuart; McGuire, Alistair; Jacobs, Ian J.; Parmar, Mahesh; Menon, Usha
picture_as_pdf
Determinants of SARS-CoV-2 outcomes in patients with cancer vs controls without cancer:a multivariable meta-analysis with genomic imputation.
Cheng, Mark T.K.; Morris, James S.; Shah, Syed F.H.; Tolley, Abraham; Chen-Xu, José; Sogandji, Nihal; Fong, Long H.; Irodi, Anushka; Chan, Justine T.N.; Kamelian, Kimia; Sievers, Benjamin L.; Sarela, Shazia; Ho, Margaret K.; Burn, Abigail; Patel, Anita; Mbolo, Ghislaine D.; Hasan, Muhammad; Fehintola, Abdulbasit O.; Yin, Chan C.; Spata, Enti; Gupta, Ravindra K.; Favara, David M.
picture_as_pdf
Trends in avoidable mortality from cardiovascular diseases in the European Union, 1995–2020:a retrospective secondary data analysis. (2024)
Cherla, Avi; Kyriopoulos, Ilias; Pearcy, Pauline; Tsangalidou, Zoi; Hajrulahovic, Haris; Theodorakis, Pavlos; Andersson, Charlotte E.; Mehra, Mandeep R.; Mossialos, Elias
picture_as_pdf
Cost-effectiveness of cancer drugs:comparative analysis of the United States and England.
Cherla, Avi; Renwick, Matthew; Jha, Ashish; Mossialos, Elias
picture_as_pdf
Ovarian cancer symptoms, routes to diagnosis and survival – population cohort study in the ‘no screen’ arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Dilley, James; Burnell, Matthew; Gentry-Maharaj, Aleksandra; Ryan, Andy; Neophytou, Christina; Apostolidou, Sophia; Karpinskyj, Chloe; Kalsi, Jatinderpal; Mould, Tim; Woolas, Robert; Singh, Naveena; Widschwendter, Martin; Fallowfield, Lesley; Campbell, Stuart; Skates, Steven J.; McGuire, Alistair; Parmar, Mahesh; Jacobs, Ian; Menon, Usha
picture_as_pdf
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer – An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). (2023)
Dilley, James; Gentry-Maharaj, Aleksandra; Ryan, Andy; Burnell, Matthew; Manchanda, Ranjit; Kalsi, Jatinderpal; Singh, Naveena; Woolas, Robert; Sharma, Aarti; Williamson, Karin; Mould, Tim; Fallowfield, Lesley; Campbell, Stuart; Skates, Steven J.; McGuire, Alistair; Parmar, Mahesh; Jacobs, Ian; Menon, Usha
picture_as_pdf
Integrative management of pancreatic Cancer (PDAC):emerging complementary agents and modalities.
Djamgoz, Mustafa B.A.; Jentzsch, Valerie
picture_as_pdf
Costs of breast cancer treatment in the United Kingdom.
Dolan, Paul; Torgerson, D.; Wolstenholme, J.
Cost minimization analysis of treatments for metastatic HER2-positive breast cancer in Peru:fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injections.
Figallo, Miguel; Delgado, María F.; Gonzalez, Mauricio; Arenas, Adrián
picture_as_pdf
Preferences for speed of access versus certainty of the survival benefit of new cancer drugs:a discrete choice experiment.
Forrest, Robin; Lagarde, Mylene; Aggarwal, Ajay; Naci, Huseyin
picture_as_pdf
Real-world use of and spending on new oral targeted cancer Drugs in the US, 2011-2018.
Fu, Mengyuan; Naci, Huseyin; Booth, Christopher M.; Gyawali, Bishal; Cosgrove, Austin; Toh, Sengwee; Xu, Ziyue; Guan, Xiaodong; Ross-Degnan, Dennis; Wagner, Anita K.
Colocteral cancer management and prevention policies in Greece.
Geitona, Mary; Kanavos, Panos
Living arrangements and place of death of older people with cancer in England and Wales: a record linkage study.
Grundy, Emily; Mayer, D.; Young, H.; Sloggett, Andy
Assessing the cost-effectiveness of imaging technology: recent results, problems and progress in the UK.
Hutton, John
The delicate balancing act of accelerated approval for cancer medicines—speed, certainty, and benefit. (2025)
Jenei, Kristina; Booth, Christopher M.
picture_as_pdf
Trends in time to withdrawal and full approval of accelerated approval cancer drug indications (1992–2024). (2025)
Jenei, Kristina; Hahn, Georg; Kesselheim, Aaron S.; Tibau, Ariadna
picture_as_pdf
Health technology assessment for cancer medicines across the G7 countries and Oceania:an international, cross-sectional study. (2023)
Jenei, Kristina; Raymakers, Adam J.N.; Bayle, Arnaud; Berger-Thürmel, Karin; Cherla, Avi; Honda, Kazunori; Jackson, Christopher C.G.A.; Karikios, Deme; Trapani, Dario; Berry, Scott; Gyawali, Bishal
Costs and causes of oncology drug attrition with the example of insulin-like growth factor-1 receptor inhibitors. (2023)
Jentzsch, Valerie; Osipenko, Leeza; Scannell, Jack W.; Hickman, John A.
picture_as_pdf
Retrospective observational cohort study on innovation in oncology and progress in survival:how far have we gotten in the two decades of treating patients with advanced non-small cell lung cancer as a single population?
Justo, Nahila; Nilsson, Jonas; Korytowsky, Beata; Dalen, Johan; Madison, Terri; McGuire, Alistair
picture_as_pdf
Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar.
Kalsi, Jatinderpal K.; Ryan, Andy; Gentry-Maharaj, Aleksandra; Margolin-Crump, Danielle; Singh, Naveena; Burnell, Matthew; Benjamin, Elizabeth; Apostolidou, Sophia; Habib, Mariam; Massingham, Susan; Karpinskyj, Chloe; Woolas, Robert; Widschwendter, Martin; Fallowfield, Lesley; Campbell, Stuart; Skates, Steven; McGuire, Alistair; Parmar, Max; Jacobs, Ian; Menon, Usha
picture_as_pdf
The burden of colorectal cancer: prevention, treatment and quality of services.
Kanavos, Panos; Schurer, Willemien
The dynamics of colorectal cancer management in 17 countries.
Kanavos, Panos; Schurer, Willemien
Use of the ESMO-magnitude of clinical benefit scale to guide HTA recommendations on coverage and reimbursement for cancer medicines:a retrospective analysis. (2024)
Kanavos, Panos; Visintin, Erica; Angelis, Aris
picture_as_pdf
Statins as a secondary preventive agent for metastatic cancer. (2023)
Marti, Juan Luis Gomez; Wells, Jakob Z.; Wells, Alan
Why do some countries approve a cancer drug and others don't?
Maynou-Pujolras, Laia; Cairns, John
The cost-effectiveness of screening for ovarian cancer:results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Menon, Usha; McGuire, Alistair J.; Raikou, Maria; Ryan, Andy; Davies, Susan K.; Burnell, Matthew; Gentry-Maharaj, Aleksandra; Kalsi, Jatinderpal K.; Singh, Naveena; Amso, Nazar N.; Cruickshank, Derek; Dobbs, Stephen; Godfrey, Keith; Herod, Jonathan; Leeson, Simon; Mould, Tim; Murdoch, John; Oram, David; Scott, Ian; Seif, Mourad W.; Williamson, Karin; Woolas, Robert; Fallowfield, Lesley; Campbell, Stuart; Skates, Steven J.; Parmar, Mahesh; Jacobs, Ian J.
Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom collaborative trial of ovarian cancer screening.
Menon, Usha; Ryan, Andy; Kalsi, Jatinderpal; Gentry-Maharaj, Aleksandra; Dawnay, Anne; Habib, Mariam; Apostolidou, Sophia; Singh, Naveena; Benjamin, Elizabeth; Burnell, Matthew; Davies, Susan; Sharma, Aarti; Gunu, Richard; Godfrey, Keith; Lopes, Alberto; Oram, David; Herod, Jonathan; Williamson, Karin; Seif, Mourad W.; Jenkins, Howard; Mould, Tim; Woolas, Robert; Murdoch, John B.; Dobbs, Stephen; Amso, Nazar N.; Leeson, Simon; Cruickshank, Derek; Scott, Ian; Fallowfield, Lesley; Widschwendter, Martin; Reynolds, Karina; McGuire, Alistair; Campbell, Stuart; Parmar, Mahesh; Skates, Steven J.; Jacobs, Ian
Overall survival benefits of cancer drugs initially approved by the US Food and Drug Administration on the basis of immature survival data:a retrospective analysis. (2024)
Naci, Huseyin; Zhang, Yichen; Woloshin, Steven; Guan, Xiaodong; Xu, Ziyue; Wagner, Anita K.
picture_as_pdf
Association between the use of surrogate measures in pivotal trials and health technology assessment decisions:a retrospective analysis of NICE and CADTH reviews of cancer drugs.
Pinto, Ashlyn; Naci, Huseyin; Neez, Emilie; Mossialos, Elias
picture_as_pdf
Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US.
Salas-Vega, Sebastian; Shearer, Emily; Mossialos, Elias
picture_as_pdf
Colorectal cancer management in the United Kingdom: current practice and challenges.
Schurer, Willemien; Kanavos, Panos
Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe:lessons for the accelerated approval pathway. (2024)
Shahzad, Mahnum; Naci, Huseyin; Esselen, Katharine M.; Dottino, Joseph A.; Wagner, Anita K.
picture_as_pdf
The association of cancer survival with four socioeconomic indicators: a longitudinal study of the older population of England and Wales 1981–2000.
Sloggett, Andy; Young, Harriet; Grundy, Emily
Understanding the role of GPs' gut feelings in diagnosing cancer in primary care:a systematic review and meta-analysis of existing evidence. (2020)
Smith, Claire Friedemann; Drew, Sarah; Ziebland, Sue; Nicholson, Brian D.
Price changes and within-class competition of cancer drugs in the USA and Europe:a comparative analysis. (2022)
Vokinger, Kerstin N.; Hwang, Thomas J.; Carl, David L.; Laube, Yannic; Ludwig, Wolf Dieter; Naci, Huseyin; Kesselheim, Aaron S.
Do cancer-specific websites meet patient's information needs?
Warren, Emily; Footman, Katharine; Tinelli, Michela; McKee, Martin; Knai, Cecile
Molecular testing for somatic mutations in common cancers: the views of UK oncologists.
Wordsworth, Sarah; Buchanan, J.; Papanicolas, Irene; Taylor, J.; Frayling, I.; Tomlinson, I.
Molecular testing for somatic cancer mutations: a survey of current and future testing in UK laboratories.
Wordsworth, Sarah; Papanicolas, Irene; Buchanan, J.; Frayling, I.; Taylor, J.; Tomlinson, I.